𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled and randomized trial about α2b-recombinant interferon in the treatment of chronic active hepatitis (CAH) HBS Ac+ with or without upper infection with delta viruses (DV)

✍ Scribed by Buligescu, L.; Babes, V.; Popescu, A.; Voiculescu, M.; Snanache, S.

Book ID
122035544
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
45 KB
Volume
9
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized, double-blind, pla
A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA
📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB